Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer

Irina Nazarenko1, Marcel Jenny, Jana Keil

  • 1Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Hermann von Helmholtz Platz 1, Eggenstein-Leopoldshafen, Germany. irina.nazarenko@kit.edu

Insights

Protein Kinase C zeta (PKCzeta) promotes ovarian cancer cell survival. Its inhibition by PP2A or HRSL3 leads to apoptosis, suggesting PKCzeta as a therapeutic target for ovarian carcinoma.

Area of Science:

  • Cellular signaling pathways
  • Molecular mechanisms of cancer

Background:

  • Protein Kinase C (PKC) family regulates cell proliferation, motility, and survival.
  • Ovarian carcinoma is a significant health concern, necessitating research into its underlying molecular mechanisms.

Purpose of the Study:

  • Investigate the role of specific PKC isoenzymes in apoptosis induction in ovarian carcinoma cells.
  • Determine the relationship between PKC isoenzymes, protein phosphatase 2A (PP2A), and HRSL3 tumor suppressor in cell death pathways.

Main Methods:

  • Measured phosphorylation and activity of PKC isoenzymes in OVCAR-3 cells under various conditions (PP2A/PI3K inhibition, HRSL3 overexpression).
  • Utilized isoform-specific peptide inhibitors and overexpression techniques to assess PKCzeta's role in apoptosis.
  • Analyzed PKCzeta expression levels in human ovarian carcinoma tissues and primary patient cells.

Main Results:

  • PKC epsilon, zeta, and iota were regulated by PP2A and/or HRSL3, unlike PKCalpha and beta.
  • PKCzeta was identified as a key mediator in PP2A- and HRSL3-dependent apoptosis, indicating a proapoptotic function.
  • High PKCzeta expression in ovarian carcinomas correlated with poor prognosis, and patient cells showed increased PKCzeta phosphorylation and apoptosis upon okadaic acid treatment.

Conclusions:

  • PKCzeta plays a crucial role in the survival of ovarian carcinoma cells.
  • Targeting PKCzeta or understanding its regulation by upstream pathways may offer novel therapeutic strategies for ovarian cancer.
  • Upregulation of tyrosine kinase receptors in ovarian tumors might impact apoptosis via negative regulation of PKCzeta.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...